MR

Millie Ray

Partner at The Column Group

United States

Overview 

Millie Ray is a Partner at The Column Group, with a background in genomics and biochemistry, having held roles at prestigious institutions like Massachusetts General Hospital and the Broad Institute. She has successfully invested in companies like Casma Therapeutics and Hexagon Bio, focusing on stages like Seed and Series B in sectors such as BioTech and Digital Health.

Work Experience 

TC

The Column Group

  • Partner

    2022 - Current

  • Principal

    2019 - 2022

  • Associate

    2017 - 2018

Foghorn Therapeutics

  • Business Associate

    2016 - 2017

FV

Flagship Ventures - Venture Labs

  • Fellow and Associate

    2015 - 2016

Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.

flagshippioneering.com
MG

Massachusetts General Hospital

  • Graduate Student and Post- Doctoral Researcher- Kingston Lab

    2008 - 2015

BI

Broad Institute

  • Ebola Genomics team - Sabeti Lab

    2014 - 2015

    Implemented first Next Generation Sequencer to run in West Africa for high capacity Ebola surveillance and diagnostics tools.

Education 

Investments 

Casma Therapeutics

Series B

Total funding: $160M

Hexagon Bio

Series A

Total funding: $190M

Articles About Millie

Relevant Websites